Predictive factors of survival in a surgical series of metastatic epidural spinal cord compression and complete external validation of 8 multivariate models of survival in a prospective North American multicenter study
- PMID: 29975401
- DOI: 10.1002/cncr.31585
Predictive factors of survival in a surgical series of metastatic epidural spinal cord compression and complete external validation of 8 multivariate models of survival in a prospective North American multicenter study
Abstract
Background: This study was designed to identify preoperative predictors of survival in surgically treated patients with metastatic epidural spinal cord compression (MESCC), to examine how these predictors are related to 8 prognostic models, and to perform the first full external validation of these models in accordance with the Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD) statement.
Methods: One hundred forty-two surgically treated patients with MESCC were enrolled in a prospective, multicenter North American cohort study and were followed for 12 months or until death. Cox regression was used. Noncollinear predictors with < 10% missing data, with ≥ 10 events per stratum, and with P < .05 in a univariate analysis were tested through a backward stepwise selection. For the original and revised Tokuhashi prognostic scoring systems (PSSs), Tomita PSS, modified Bauer PSS, van der Linden PSS, Bartels model, Oswestry Spinal Risk Index, and Bollen PSS, this study examined calibration graphically, discrimination with Harrell c-statistics, and survival stratified by risk groups with the Kaplan-Meier method and log-rank test.
Results: The following were significant in the univariate analysis: type of primary tumor, sex, organ metastasis, body mass index, preoperative radiotherapy to MESCC, physical component (PC) of the 36-Item Short Form Health Survey, version 2 (SF-36v2), and EuroQol 5-Dimension (EQ-5D) Questionnaire. Breast, prostate and thyroid primary tumor (HR: 2.9; P =.0005), presence of organ metastasis (hazard ratio (HR): 2.0; P = .005) and SF-36v2 PC (HR: 0.95; P < .0001) were associated with survival in multivariable analysis. Predicted prognoses poorly matched observed values on calibration plots; Bartels model calibration slope was 0.45. Bollen PSS (0.61; 95% CI: 0.58-0.64) and Bartels model (0.68; 95% CI: 0.65-0.71) had the lowest and highest c-statistics, respectively.
Conclusions: The primary tumor type (breast, prostate, or thyroid), an absence of organ metastasis, and a lower degree of physical disability are preoperative predictors of longer survival for surgical MESCC patients. These results are in keeping with current models. This full external validation of 8 prognostic PSSs or model of survival in surgical MESCC patients has revealed that calibration is poor, especially for long-term survivors, whereas discrimination is possibly helpful.
Keywords: external validation; metastatic epidural spinal cord compression; predictive factors; prospective study; survival.
© 2018 American Cancer Society.
Similar articles
-
A Personalized Medicine Approach for the Management of Spinal Metastases with Cord Compression: Development of a Novel Clinical Prediction Model for Postoperative Survival and Quality of Life.World Neurosurg. 2020 Aug;140:654-663.e13. doi: 10.1016/j.wneu.2020.03.098. World Neurosurg. 2020. PMID: 32797992
-
Survival and Clinical Outcomes in Surgically Treated Patients With Metastatic Epidural Spinal Cord Compression: Results of the Prospective Multicenter AOSpine Study.J Clin Oncol. 2016 Jan 20;34(3):268-76. doi: 10.1200/JCO.2015.61.9338. Epub 2015 Nov 23. J Clin Oncol. 2016. PMID: 26598751
-
Prognostic Factors and a Survival Score in Patients Irradiated for Metastatic Epidural Spinal Cord Compression from Urothelial Carcinoma Cancer of the Bladder.Anticancer Res. 2018 Dec;38(12):6841-6846. doi: 10.21873/anticanres.13058. Anticancer Res. 2018. PMID: 30504399
-
The role of radiotherapy for metastatic epidural spinal cord compression.Nat Rev Clin Oncol. 2010 Oct;7(10):590-8. doi: 10.1038/nrclinonc.2010.137. Epub 2010 Aug 31. Nat Rev Clin Oncol. 2010. PMID: 20808299 Review.
-
Metastatic epidural cord compression.Curr Neurol Neurosci Rep. 2004 May;4(3):191-5. doi: 10.1007/s11910-004-0038-0. Curr Neurol Neurosci Rep. 2004. PMID: 15102344 Review.
Cited by
-
Preoperative Predictors of Survival in Patients With Spinal Metastatic Disease.Int J Spine Surg. 2023 Aug;17(4):557-563. doi: 10.14444/8444. Epub 2023 Mar 8. Int J Spine Surg. 2023. PMID: 36889904 Free PMC article.
-
Practice variations in indication, timing and outcome of Multiple Myeloma patients undergoing surgery for vertebral lesions - results from the European M2Spine study group.J Neurooncol. 2025 Sep;174(3):765-777. doi: 10.1007/s11060-025-05085-y. Epub 2025 Jun 13. J Neurooncol. 2025. PMID: 40512280 Free PMC article.
-
Development and internal validation of machine-learning models for predicting survival in patients who underwent surgery for spinal metastases.Asian Spine J. 2024 Jun;18(3):325-335. doi: 10.31616/asj.2023.0314. Epub 2024 May 20. Asian Spine J. 2024. PMID: 38764230 Free PMC article.
-
Treatment Strategy for Metastatic Spinal Tumors: A Narrative Review.Asian Spine J. 2020 Aug;14(4):513-525. doi: 10.31616/asj.2020.0379. Epub 2020 Aug 13. Asian Spine J. 2020. PMID: 32791769 Free PMC article.
-
Contemporary trends in the incidence and timing of spinal metastases: A population-based study.Neurooncol Adv. 2024 Apr 18;6(1):vdae051. doi: 10.1093/noajnl/vdae051. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38680988 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources